Skip to main content
Smart Investors Daily
PE

NASDAQ · PEAR

Pear Therapeutics, Inc.

Healthcare · Medical - Healthcare Information Services

$0.03

Up+$0.00 (+0.00%)

Updated Sep 30, 2026, 9:06 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
4.09M
P/E ratio
-0.17
Dividend yield
0.00%
52-week range
— – —
Volume
66.3M
Avg. volume
10.09M

Price performance · PEAR

PEAR price history

1M range · 0 trading sessions · Daily adjusted prices

PEAR does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest PEAR news

The latest Smart Investors Daily articles mentioning PEAR.

PEAR research

Overview

Company profile and research snapshot.

Company profile

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$6.50
Implied upside
—
Analysts
—
PEAR recent ratings
DateFirmRatingTarget
Mar 20, 2023TD CowenMarket Perform—
Mar 20, 2023Chardan CapitalNeutral—
Mar 20, 2023Credit SuisseNeutral—
Nov 16, 2022CitigroupBuy—
Nov 15, 2022Chardan CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Apr 10, 2023

Dow Turns Positive; Greenbrier Shares Spike Higher

U.S. stocks traded mixed toward the end of trading, with the Dow Jones turning higher on Monday. The Dow traded up 0.03% to 33,496.17 while the NASDAQ fell 0.30% to 12,052.14. The S&P 500, also fell, dropping, 0.19% to 4,097.15. Check This Out: Top 5 Utilities Stocks That You May Want To Dump In Q2   Leading and Lagging Sectors Energy shares rose by 0.9% on Monday. Meanwhile, top gainers in the sector included Communication Services (NASDAQ: BANL), up 18%, and Verde Clean Fuels, Inc. (NASDAQ: VGAS), up 8%. In trading on Monday, communication services fell by 0.8%.   Top Headline Greenbrier Companies Inc (NYSE: GBX) reported solid Q2 results and raised FY23 outlook. The company reported second-quarter FY23 sales growth of 64% year-on-year, to $1.12 billion, beating the consensus of $782.27 million. Adjusted EPS of $0.99 beat the analyst consensus of $0.36.   Equities Trading UP Arrival (NASDAQ: ARVL) shares shot up 22% to $0.1494 after the company announced a business combination with Kensington Capital Acquisition Corp. V. Shares of Ebix, Inc. (NASDAQ: EBIX) got a boost, ...

Benzinga · Apr 10, 2023

Gold Down Over 1%; US Wholesale Inventories Increase 0.1%

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Monday. The Dow traded down 0.10% to 33,450.96 while the NASDAQ fell 0.93% to 11,975.59. The S&P 500, also fell, dropping, 0.57% to 4,081.50. Check This Out: Top 5 Utilities Stocks That You May Want To Dump In Q2   Leading and Lagging Sectors Energy shares rose by 0.9% on Monday. Meanwhile, top gainers in the sector included Communication Services (NASDAQ: BANL), up 16%, and YPF Sociedad Anónima (NYSE: YPF), up 10%. In trading on Monday, communication services fell by 1.2%.   Top Headline Wholesale inventories in the U.S. rose 0.1% from a month ago in February, compared to the preliminary estimate of a 0.2% increase and compared to a revised 0.6% drop in January.   Equities Trading UP Arrival (NASDAQ: ARVL) shares shot up 33% to $0.1626 after the company announced a business combination with Kensington Capital Acquisition Corp. V. Shares of Ebix, Inc. (NASDAQ: EBIX) got a boost, shooting 19% to $15.52. Ebix named executive Amit K. ...

Benzinga · Mar 22, 2023

Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket

Gainers Virgin Orbit Holdings, Inc. (NASDAQ: VORB) shares rose 81.2% to $0.8032 in pre-market trading. Richard Branson's Virgin Orbit is nearing a deal for a $200 million investment from Texas-based Venture Capital investor Matthew Brown via a private share placement, according to a term sheet. GameStop Corp. (NYSE: GME) climbed 43.7% to $25.37 in pre-market trading after the company reported better-than-expected Q4 results. Diebold Nixdorf, Incorporated (NYSE: DBD) gained 23.1% to $0.9746 in pre-market trading. Diebold Nixdorf confirms closing on $55 million of additional liquidity. Lixiang Education Holding Co., Ltd. (NASDAQ: LXEH) gained 22.1% to $0.88 in pre-market trading after dropping 13% on Tuesday. Pyxis Oncology, Inc. (NASDAQ: PYXS) rose 21.4% to $2.67 in pre-market after dropping around 7% on Tuesday. Blue Water Vaccines, Inc. (NASDAQ: BWV) gained 16.2% to $1.22 in pre-market trading. Blue Water Vaccines recently posted upbeat FY22 earnings. Telesis Bio, Inc. (NASDAQ: TBIO) shares rose 12.2% to $2.48 in pre-market trading following better-than-expected Q4 results. Hempacco ...

Benzinga · Mar 20, 2023

Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023

Upgrades According to Seaport Global, the prior rating for Sonoco Products Co (NYSE:SON) was changed from Neutral to Buy. Sonoco Prods earned $1.27 in the fourth quarter, compared to $0.90 in the year-ago quarter. The stock has a 52-week-high of $67.06 and a 52-week-low of $51.63. At the end of the last trading period, Sonoco Prods closed at $54.10. According to Maxim Group, the prior rating for Panbela Therapeutics Inc (NASDAQ:PBLA) was changed from Hold to Buy. Panbela Therapeutics earned $5.68 in the fourth quarter, compared to $10.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $87.60 and a 52-week-low of $0.41. Panbela Therapeutics closed at $0.51 at the end of the last trading period. Northcoast Research upgraded the previous rating for Live Nation Entertainment Inc (NYSE:LYV) from Neutral to Buy. For the fourth quarter, Live Nation Entertainment had an EPS of $1.09, compared to year-ago quarter EPS of $0.96. The current stock performance of Live Nation Entertainment shows a 52-week-high of $121.17 and a 52-week-low of $65.11. Moreover, at the end of the last trading period, the closing price was at $66.34. US Tiger Securities, Inc upgraded the previous rating for Coinbase Global Inc (NASDAQ:COIN) from Hold to Buy. In the fourth quarter, Coinbase Glb showed an EPS of $2.46, compared to $3.32 from the year-ago quarter. The current stock performance of Coinbase Glb shows a 52-week-high of $206.78 and a 52-week-low of $31.55. Moreover, at the end of the last trading period, the closing price was at $74.98. Exane BNP Paribas upgraded the previous rating for The Beauty Health Co (NASDAQ:SKIN) from Underperform to Neutral. Beauty Health earned $0.05 in the fourth quarter, compared to $0.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.37 and a 52-week-low of $8.26. Beauty Health closed at $11.31 at the end of the last trading period. Northcoast Research upgraded the previous rating for The Kroger Co (NYSE:KR) from Neutral to Buy. In the fourth quarter, Kroger showed an EPS of $0.99, compared to $0.91 from the year-ago quarter. The stock has a 52-week-high of $62.74 and a 52-week-low of $41.81. At the end of the last trading period, Kroger closed at $46.78. According to B of A Securities, the prior rating for NRG Energy Inc (NYSE:NRG) was changed from Neutral to Buy. NRG Energy earned $4.56 in the fourth quarter, compared to $1.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.78 and a 52-week-low of $30.25. NRG Energy closed at $31.48 at the end of the last trading period. Wolfe Research upgraded the previous rating for United States Steel Corp (NYSE:X) from Underperform to Peer Perform. For the fourth quarter, United States Steel had an EPS of $0.87, compared to year-ago quarter EPS of $3.64. At the moment, the stock has a 52-week-high of $39.24 and a 52-week-low of $16.42. United States Steel closed at $23.97 at the end of the last trading period. For Cleveland-Cliffs Inc (NYSE:CLF), Wolfe Research upgraded the previous rating of Underperform to Peer Perform. In the fourth quarter, Cleveland-Cliffs showed an EPS of $0.30, compared to $1.78 from the year-ago quarter. At the moment, the stock has a 52-week-high of $34.03 and a 52-week-low of $11.82. Cleveland-Cliffs closed at $17.36 at the end of the last trading period. According to Redburn Partners, the prior rating for Verisk Analytics Inc (NASDAQ:VRSK) was changed from Sell to Neutral. For the fourth quarter, Verisk Analytics had an EPS of $1.43, compared to year-ago quarter EPS of $1.47. The current stock performance of Verisk Analytics shows a 52-week-high of $222.11 and a 52-week-low of $156.07. Moreover, at the end of the last trading period, the closing price was at $180.07. Benchmark upgraded the previous rating for Aspen Aerogels Inc (NYSE:ASPN) from Hold to Buy. Aspen Aerogels earned $0.20 in the fourth quarter, compared to $0.50 in the year-ago quarter. The current stock performance of Aspen Aerogels shows a 52-week-high of $38.00 and a 52-week-low of $6.37. Moreover, at the end of the last trading period, the closing price was at $6.81. William Blair upgraded the previous rating for VF Corp (NYSE:VFC) from Sell to Buy. For the third quarter, VF had an EPS of $1.12, compared to year-ago quarter EPS of $1.35. The current stock performance of VF shows a 52-week-high of $60.02 and a 52-week-low of $20.14. Moreover, at the end of the last trading period, the closing price was at $21.42. For Brookfield Corp (NYSE:BN), Credit Suisse upgraded the previous rating of Neutral to Outperform. For the fourth quarter, Brookfield had an EPS of $1.12, compared to year-ago quarter EPS of $1.04. The stock has a 52-week-high of $48.17 and a 52-week-low of $28.25. At the end of the last trading period, Brookfield closed at $28.62. According to Citigroup, the prior rating for WestRock Co (NYSE:WRK) was changed from Neutral to Buy. For the first quarter, WestRock had an EPS of $0.55, compared to year-ago quarter EPS of $0.65. The stock has a 52-week-high of $54.76 and a 52-week-low of $26.84. At the end of the last trading period, WestRock closed at $27.07. Bernstein upgraded the previous rating for PepsiCo Inc (NASDAQ:PEP) from Underperform to Market Perform. PepsiCo earned $1.67 in the fourth quarter, compared to $1.53 in the year-ago quarter. The current stock performance of PepsiCo shows a 52-week-high of $186.81 and a 52-week-low of $154.86. Moreover, at the end of the last trading period, the closing price was at $175.13. Wedbush upgraded the previous rating for New York Community Bancorp Inc (NYSE:NYCB) from Neutral to Outperform. New York Community earned $0.25 in the fourth quarter, compared to $0.31 in the year-ago quarter. The current stock performance of New York Community shows a 52-week-high of $11.29 and a 52-week-low of $5.81. Moreover, at the end of the last trading period, the closing price was at $6.54. Edward Jones upgraded the previous rating for Meta Platforms Inc (NASDAQ:META) from Hold to Buy. ...Full story available on Benzinga.com

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.